Literature DB >> 32079389

Increased Bone Marrow 18F-Choline Uptake in a Patient with Hepatocellular Carcinoma and Thalassemia Intermedia

Luca Filippi1.   

Abstract

A 57-year-old male with history of thalassemia intermedia and hepatocellular carcinoma underwent a positron emission tomography/computed tomography (PET/CT) scan with 18F-choline before radioembolization procedure with 90Y-microspheres. The PET/CT scan with 18F-choline demonstrated highly increased tracer incorporation within a gross lesion in the hepatic dome coupled with diffuse activity in bone marrow, this latter aspect was probably due to the compensatory hematopoiesis stimulation induced by chronic hemolysis. This pattern of skeletal 18F-choline uptake should be considered as a peculiar PET/CT finding in thalassemic patients.

Entities:  

Keywords:  18F-choline; positron emission tomography/computed tomography; hepatocellular carcinoma; thalassemia

Year:  2020        PMID: 32079389      PMCID: PMC7057729          DOI: 10.4274/mirt.galenos.2019.03064

Source DB:  PubMed          Journal:  Mol Imaging Radionucl Ther        ISSN: 2146-1414


  8 in total

1.  Evaluating Treatment Response of Radioembolization in Intermediate-Stage Hepatocellular Carcinoma Patients Using 18F-Fluoroethylcholine PET/CT.

Authors:  Markus Hartenbach; Stefan Weber; Nathalie L Albert; Sabrina Hartenbach; Albert Hirtl; Mathias J Zacherl; Philipp M Paprottka; Reinhold Tiling; Peter Bartenstein; Marcus Hacker; Alexander R Haug
Journal:  J Nucl Med       Date:  2015-09-24       Impact factor: 10.057

2.  18F-choline PET/CT physiological distribution and pitfalls in image interpretation: experience in 80 patients with prostate cancer.

Authors:  Orazio Schillaci; Ferdinando Calabria; Mario Tavolozza; Carmelo Cicciò; Marco Carlani; Cristiana R Caracciolo; Roberta Danieli; Antonio Orlacchio; Giovanni Simonetti
Journal:  Nucl Med Commun       Date:  2010-01       Impact factor: 1.690

3.  Use of 18F-Fluciclovine to Diagnose Recurrent Prostate Carcinoma in a Patient With Beta-Thalassemia.

Authors:  Chelsea R Schmitt; Christian T Schmitt; Peter R Hinds; Kevin J Sawyer
Journal:  Clin Nucl Med       Date:  2019-09       Impact factor: 7.794

4.  Hepatocellular carcinoma in thalassemia: A critical review.

Authors:  Andrea Mancuso
Journal:  World J Hepatol       Date:  2010-05-27

Review 5.  Recent advances in PET probes for hepatocellular carcinoma characterization.

Authors:  Luca Filippi; Orazio Schillaci; Oreste Bagni
Journal:  Expert Rev Med Devices       Date:  2019-04-28       Impact factor: 3.166

6.  Incidental detection of colorectal cancer via 1(8)F-choline PET/CT in a patient with recurrent prostate cancer: usefulness of early images.

Authors:  Oreste Bagni; Luca Filippi; Orazio Schillaci
Journal:  Clin Nucl Med       Date:  2015-06       Impact factor: 7.794

Review 7.  Imaging of Prostate Cancer Using Fluciclovine.

Authors:  Bital Savir-Baruch; Lucia Zanoni; David M Schuster
Journal:  Urol Clin North Am       Date:  2018-06-15       Impact factor: 2.241

Review 8.  Heart disease in thalassemia intermedia: a review of the underlying pathophysiology.

Authors:  Athanasios Aessopos; Maria Kati; Dimitrios Farmakis
Journal:  Haematologica       Date:  2007-05       Impact factor: 9.941

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.